Lind Global Macro Fund LP 13D and 13G filings for EyeGate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-17 4:45 pm Purchase | 2021-08-11 | 13G | EyeGate Pharmaceuticals, Inc. EYEG | Lind Global Macro Fund LP | 1,302,933 9.900% | 1,302,933 (New Position) | Filing |